Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers
Инновации в терапии рака: липосомы, реагирующие на эндогенные стимулы, как современные нанопереносчики
2025-02-13
SCID: 54.1/rzewbq3f
Discuss with AI
cancer therapydual- and multi-responsive liposomesendogenous stimuliliposomal nanocarriersstimuli-responsive liposomes
Figures from the paper
Abstract (AI)
Recent advancements in nanotechnology have revolutionized cancer therapy-one of the most pressing global health challenges and a leading cause of death-through the development of liposomes (L), lipid-based nanovesicles known for their biocompatibility and ability to encapsulate both hydrophilic and lipophilic drugs. More recent innovations have led to the creation of stimuli-responsive L that release their payloads in response to specific endogenous or exogenous triggers. Dual- and multi-responsive L, which react to multiple stimuli, offer even greater precision, improving therapeutic outcomes while reducing systemic toxicity. Additionally, these smart L can adjust their physicochemical properties and morphology to enable site-specific targeting and controlled drug release, enhancing treatment efficacy while minimizing adverse effects. This review explores the latest advancements in endogenous stimuli-responsive liposomal nanocarriers, as well as dual- and multi-responsive L that integrate internal and external triggers, with a focus on their design strategies, mechanisms, and applications in cancer therapy.
Key Findings
1
Dual- and multi-responsive liposomes combine multiple endogenous or external stimuli to improve treatment precision and potentially reduce systemic toxicity.
2
Endogenous stimuli-responsive liposomes release therapeutic payloads in response to specific internal biological triggers, enabling controlled drug delivery.
3
Liposomes provide biocompatible nanocarriers capable of encapsulating both hydrophilic and lipophilic anticancer drugs.
4
Stimuli-responsive liposomes can alter their physicochemical properties and morphology to support site-specific targeting and controlled release.
5
The review examines design strategies, response mechanisms, and cancer-therapy applications of endogenous, dual-, and multi-responsive liposomal nanocarriers.
Research Object
endogenous stimuli-responsive liposomal nanocarriers for cancer therapy
Research Subject
design strategies, response mechanisms, site-specific targeting, and controlled drug release of single-, dual-, and multi-responsive liposomes under endogenous and integrated internal/external stimuli
Publication Details
Publication Date
2025-02-13
Journal
Publisher
ISSN
Cited by
39
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest